we implemented a new segment reporting structure commencing with the second quarter of 2021, which resulted in four reportable segments: u.s. pharmaceutical, international, medical-surgical solutions, and prescription technology solutions ("rxts"). other, for retrospective periods presented, consists of our equity method investment in change healthcare llc ("change healthcare jv"), which was split-off from mckesson in the fourth quarter of 2020. all prior segment information has been recast to reflect our new segment structure and current period presentation. our organizational structure also includes corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. the factors for determining the reportable segments include the manner in which management evaluates the performance of the company combined with the nature of individual business activities. we evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes.